Talk:Neuraminidase: Difference between revisions
Content deleted Content added
| Line 1: | Line 1: | ||
{{Wikiproject MCB}} |
{{Wikiproject MCB}} |
||
== '''Q: Can [[N1..N9]] be used [[directly]] as a flu [[vaccine]] (with a promoter) ?''' == |
|||
'''IF''' |
|||
(1) there are a limited number of types of Neuraminidases (9 according to the article), |
|||
(2) if at least one type of Neuraminidases is present on every flu viron, |
|||
(3) if Neuraminidases subtypes (ex : N2) can be specifically recognized |
|||
as antigens by the immune system, and |
|||
(4) the immugenic epitopes on each Neuraminidases subtype are reasonably |
|||
well conserved over various flu virus mutations, |
|||
'''then''' |
|||
can '''vaccines''' be developped that '''DIRECTLY target Neuraminidases ''' - |
|||
(eg. a cocktail of N1, N2, N3..N9 with a promoter) to encourage |
|||
an immune response that is '''not diffusely aimed''' at a broad range |
|||
of viral antigens, but - rather - that is '''focussed''' on |
|||
a limited number (9) of more widely '''conserved''' antigens ? |
|||
Does anyone have information on this ? |
|||
Regards, |
|||
[[User:129.78.64.100|129.78.64.100]] 09:35, 20 February 2007 (UTC) G. Holt |
|||
(Please let me know at : ghol7955@gmp.usyd.edu.au |
|||
(Please don't spam me though!) |
|||
Thank you! |
|||
) |
|||